Status:
COMPLETED
Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer
Lead Sponsor:
Yale University
Conditions:
Cancer of the Prostate
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is to determine the safety, feasibility and acceptability of an 8-week cognitive remediation training (CRT) in patients treated for cancer. The secondary objective of the study is to estima...
Detailed Description
Objectives: The primary objective of this study is to determine the safety, feasibility and acceptability of an 8-week cognitive training intervention in patients treated for cancer. The secondary ob...
Eligibility Criteria
Inclusion
- Participants who:
- are at least six months from completion of adjuvant chemotherapy or chemoradiation and are in remission or;
- are receiving long-term chemotherapy (6 months or longer) with a diagnosis of Stage IV cancer and with stable medical conditions or;
- are receiving long-term (6 months or longer) hormone therapy (androgen deprivation therapy or anti-estrogen therapy). Patients in this group who received chemotherapy will be eligible if they completed chemotherapy at least 6 months prior to enrolling.
- 2\. Subjective reports of cognitive decline. 3. Report that they are interested in seeking treatment to address their cognitive concerns.
- 4\. Age 18 or older. 5. Fluency in English and a 6th grade or higher reading level.
Exclusion
- Does not meet one of the three participant categories
- Unstable medical condition.
- History of, or current symptoms of, serious psychiatric disorder requiring antipsychotic medications or hospitalization.
- Current substance abuse disorder.
- History of, or current central nervous system (CNS) malignancies, CNS radiation, intrathecal chemotherapy, or CNS-involved surgery.
- Current IQ estimate less than 80.
- Unable to give written informed consent.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03285048
Start Date
January 1 2017
End Date
September 1 2017
Last Update
October 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516